research use only

ITE AhR agonist

Name: ITE
Brand: Selleck Chemicals
SKU: E0143
Availability: InStock
Rating: 5 (1 reviews)

Cat.No.E0143

ITE (2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester) is a potent endogenous agonist of aryl hydrocarbon receptor (AhR) that directly binds to AHR with a Ki of 3 nM.

Chemical Structure

Molecular Weight: 286.31

Jump to Mechanism of Action Solubility Chemical Information, Storage & Stability Specificity

Quality Control

Batch: E014301 DMSO]57 mg/mL]false]Ethanol]2 mg/mL]false]Water]Insoluble]false Purity: 99.64%

99.64

Related Targets	Immunology & Inflammation related CD markers Interleukins Anti-infection Antioxidant COX Histamine Receptor TNF-alpha ROS Parasite PD-1/PD-L1 TLR Prostaglandin Receptor IFN CXCR Nrf2 NOS CCR NLRP3 eIF STING IL Receptor Complement System IRAK β-lactamase IDO/TDO PGES FKBP NADPH-oxidase LTR
Related Products	CH-223191 Stemregenin 1 (SR1) FICZ BAY-218 Tapinarof BAY 2416964 GNF351 L-Kynurenine Diosmin PDM2 CAY10465 PDM-11 AhR Antibody [A3L23] Indolelactic acid Norisoboldine Perillaldehyde

Chemical Information, Storage & Stability

Molecular Weight	286.31	Formula	C₁₄H₁₀N₂O₃S	Storage (From the date of receipt)	3 years -20°C powder
CAS No.	448906-42-1	--		Storage of Stock Solutions	1 year-80°Cin solvent 1 month-20°Cin solvent
Synonyms	2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester			Smiles	COC(=O)C1=CSC(=N1)C(=O)C2=C[NH]C3=CC=CC=C23

Solubility

In vitro
Batch:

DMSO : 57 mg/mL (199.08 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 2 mg/mL

Water : Insoluble

Molarity Calculator

Mass	Concentration	Volume	Molecular Weight
=	×	×

Dilution Calculator Molecular Weight Calculator

In vivo Batch:
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5%DMSO 1 40%PEG300 2 5%Tween80 3 50%ddH2O Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.	1.450mg/ml (5.06mM)	Taking the 1 mL working solution as an example, add 50 μL of 29 mg/ml clarified DMSO stock solution to 400 μL PEG300, mix evenly to clarify it; add 50 μL Tween80 to the above system, mix evenly to clarify it; then continue to add 500 μL ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.
Clear solution	5% DMSO 1 95% corn oil Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.	0.700mg/ml (2.44mM)	Taking the 1 mL working solution as an example, add 50 μL of 14 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results.

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC₅₀/Ki	AhR ^[1] 3 nM(Ki)
References	[1] https://pubmed.ncbi.nlm.nih.gov/12409613/

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT04262271	Completed	Respiratory Disease	Portsmouth Hospitals NHS Trust	August 7 2019	--
NCT03938610	Recruiting	Knowledge Attitudes Practice	Pamela Hughes\|Mike O''Callaghan Military Hospital	June 1 2019	--
NCT03675308	Active not recruiting	Psoriatic Arthritis	AbbVie	March 25 2019	Phase 3
NCT03671148	Active not recruiting	Psoriatic Arthritis (PsA)	AbbVie	March 7 2019	Phase 3
NCT02709486	Completed	Osteoarthritis Hip\|Osteoarthritis Knee	Pfizer\|Eli Lilly and Company	March 2 2016	Phase 3

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):